Free Account Opening + AMC Free Demat
Loading...

Glenmark Life Sciences IPO vs Ruchi Soya FPO

Comparision between Glenmark Life Sciences IPO and Ruchi Soya FPO.

IPO Details

Glenmark Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Ruchi Soya FPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Glenmark Life Sciences IPO is up to ₹1,513.60 Cr whereas the issue size of the Ruchi Soya FPO is up to ₹4,300.00 Cr. The final issue price of Glenmark Life Sciences IPO is ₹720.00 per share and of Ruchi Soya FPO is ₹650.00 per share.

  Glenmark Life Sciences IPO Ruchi Soya FPO
Face Value ₹2 per share ₹2 per share
Issue Price (Lower) ₹695.00 per share ₹615.00 per share
Issue Price (Upper) ₹720.00 per share ₹650.00 per share
Issue Price (Final) ₹720.00 per share ₹650.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 20 shares 21 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹1,060.00 Cr
OFS Issue Size 63,00,000 shares
OFS Issue Size (Amount) up to ₹453.60 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹1,513.60 Cr up to ₹4,300.00 Cr

IPO Timetable

Glenmark Life Sciences IPO opens on Jul 27, 2021, while Ruchi Soya FPO opens on Mar 24, 2022. The closing date of Glenmark Life Sciences IPO and Ruchi Soya FPO is Jul 29, 2021, and Mar 28, 2022, respectively.

  Glenmark Life Sciences IPO Ruchi Soya FPO
Anchor Bid Date
Issue Open Jul 27, 2021 Mar 24, 2022
Issue Close Jul 29, 2021 Mar 28, 2022
Basis Of Allotment (Tentative) Aug 03, 2021 Apr 05, 2022
Initiation of Refunds (Tentative) Aug 04, 2021 Apr 06, 2022
Credit of Share (Tentative) Aug 05, 2021 Apr 07, 2022
Listing date (Tentative) Aug 06, 2021 Apr 08, 2022
Anchor Lockin End date 1 Sep 02, 2021 May 05, 2022
Anchor Lockin End date 2 Nov 01, 2021 Jul 04, 2022

Financials

Glenmark Life Sciences IPO P/E ratio is , as compared to Ruchi Soya FPO P/E ratio of 30.86.

  Glenmark Life Sciences IPO Ruchi Soya FPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Lakh)
30-Sep-21 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 941,180.62 900,881.98 786,761.13 789,427.20
Total Revenue 1,130,698.62 1,638,297.71 1,317,536.56 1,282,925.56
Profit After Tax 33,780.52 68,077.18 771,461.39 3,412.89
Promoter Shareholding (Pre-Issue) 100% 98.90%
Promoter Shareholding (Post-Issue) 82.84% 80.82%
P/E Ratio 30.86
Market Cap ₹23529.67 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Glenmark Life Sciences IPO retail investors (RII) are offered 75,43,130 shares while in Ruchi Soya FPO retail investors are offered 75,43,130 shares. Qualified institutional buyers (QIB) are offered 42,42,379 shares in Glenmark Life Sciences IPO and 3,30,71,000 shares in Ruchi Soya FPO.

  Glenmark Life Sciences IPO Ruchi Soya FPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 42,42,379 shares 3,30,71,000 shares
NII 32,32,770 shares 99,21,000 shares
RII 75,43,130 shares 2,31,50,000 shares
Employee 0 shares 10,000 shares
Others
Total 1,50,18,279 shares 6,61,52,000 shares

Bids Received (Subscription)

Glenmark Life Sciences IPO subscribed 44.17x in total, whereas Ruchi Soya FPO subscribed 3.60x.

  Glenmark Life Sciences IPO Ruchi Soya FPO
QIB (times) 36.97x 2.20x
NII (times) 122.54x 11.75x
Big NII (times)
Small NII (times)
RII (times) 14.63x 0.90x
Employee (times) 7.76x
Other (times)
Total (times) 44.17x 3.60x

Comments

Add a public comment...